The Computational Biology Market Is Estimated To Witness High Growth Owing To Wide Application In Drug Discovery
The computational biology market is estimated to be valued at US$ 6.6 Bn in 2023 and is expected to exhibit a CAGR of 17.6% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Computational biology uses computers and data to study and solve complex biological problems. It helps analyze biological data sets including gene expression, protein-protein interactions, metabolic processes and genetic variations. It supports biology research, advances biological knowledge and enables developing new treatment strategies. Key applications areas include genomics, epigenomics, proteomics, transcriptomics and pharmacogenomics among others.
Market Dynamics:
Wide adoption in drug discovery is a key driver for the market. Computational methods help identify biological targets for drug development, discover potential drug candidates in silico and optimize lead compounds. Increasing focus on precision medicine is also propelling growth. Large scale genomic data and molecular diagnostics demand sophisticated modeling tools for disease subtyping and individualized treatment regimens. Growing R&D investments in life sciences is another factor fueling demand. Computational tools enable faster and cost-effective research.
SWOT Analysis
Strength: Computational biology utilizes advanced technologies to gain insights into biological processes. It reduces costs and timelines for drug discovery and development. Researchers are able to examine thousands of potential drug candidates in silico before testing them experimentally.
Weakness: Developing computational models for complex biological systems requires huge amounts of computational power and data. Simulating whole-cell models or multicellular tissues remains a challenge. Accuracy of computational predictions depends heavily on the quality and quantity of training datasets.
Opportunity: Rapid advancements in fields like artificial intelligence, machine learning and cloud computing are enhancing the capabilities of computational biology. These technologies help generate biological insights quicker and at lower costs. Growing focus on precision medicine will further boost the adoption of computational tools for disease modelling and therapeutic design.
Threats: High dependency on skilled workforce with multi-disciplinary expertise poses challenges in human resource management. Stringent regulatory norms may delay commercialization of some computational tools and applications.
Key Takeaways:
The Global Computational Biology Market Size is expected to witness high growth, exhibiting CAGR of 17.6% over the forecast period, due to increasing demand for cost-effective drug discovery processes. Computational tools help streamline various stages of drug development like target identification, lead optimization, and clinical trial simulation. Furthermore, these approaches reduce needs for animal testing and expensive wet-lab experiments in early phases of research.
Regional analysis: North America currently dominates the computational biology market, and is expected to continue its dominance during the forecast period. This is attributed to presence of leading pharmaceutical and biotech companies and availability of substantial healthcare budgets for research activities in the US and Canada. However, Asia Pacific is expected to exhibit the highest CAGR during the forecast period owing to increasing government funding to develop domestic biotech industries and expanding capabilities of China and India in healthcare and biomedical research.
Key players operating in the computational biology market are Accelrys, Certara, L.P., Chemical Computing Group Inc., Compugen, Ltd., Entelos, Inc. (Rosa & Co. LLC), Genedata AG, Insilico Biotechnology AG, Leadscope, Inc., Nimbus Discovery LLC, Rhenovia Pharma SAS, Schrodinger, and Simulation Plus, Inc. Major players are focusing on developing AI-enabled platforms for drug discovery through inorganic strategies such as collaborations and acquisitions.
For More Insights, Read: https://www.trendingwebwire.com/computational-biology-market-trends-growth-and-regional-outlook-2023-2030/
